Information Technology Services
Compare Stocks
4 / 10Stock Comparison
NYAX vs CWAN vs VRNT vs IIIV
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Infrastructure
Software - Infrastructure
NYAX vs CWAN vs VRNT vs IIIV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Information Technology Services | Software - Application | Software - Infrastructure | Software - Infrastructure |
| Market Cap | $2.66B | $7.22B | $1.24B | $467M |
| Revenue (TTM) | $404M | $826M | $894M | $217M |
| Net Income (TTM) | $36M | $-48M | $61M | $18M |
| Gross Margin | 46.3% | 66.0% | 69.9% | 58.2% |
| Operating Margin | 9.7% | 1.4% | 8.6% | 0.7% |
| Forward P/E | 81.1x | 34.7x | 7.0x | 18.7x |
| Total Debt | $338M | $883M | $448M | $8M |
| Cash & Equiv. | $412M | $91M | $216M | $67M |
NYAX vs CWAN vs VRNT vs IIIV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 22 | May 26 | Return |
|---|---|---|---|
| Nayax Ltd. (NYAX) | 100 | 304.4 | +204.4% |
| Clearwater Analytic… (CWAN) | 100 | 145.0 | +45.0% |
| Verint Systems Inc. (VRNT) | 100 | 60.4 | -39.6% |
| i3 Verticals, Inc. (IIIV) | 100 | 105.5 | +5.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NYAX vs CWAN vs VRNT vs IIIV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NYAX carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 38.0%, EPS growth 7.4%, 3Y rev CAGR 35.7%
- 157.7% 10Y total return vs IIIV's 15.2%
- Lower volatility, beta 0.72, current ratio 2.26x
- Beta 0.72, current ratio 2.26x
CWAN is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 0.79
- 61.9% revenue growth vs IIIV's -7.3%
VRNT is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (7.0x vs 18.7x)
- 1.6% yield; the other 3 pay no meaningful dividend
IIIV lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 61.9% revenue growth vs IIIV's -7.3% | |
| Value | Lower P/E (7.0x vs 18.7x) | |
| Quality / Margins | 8.9% margin vs CWAN's -5.8% | |
| Stability / Safety | Beta 0.72 vs VRNT's 1.25 | |
| Dividends | 1.6% yield; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +74.2% vs IIIV's -21.4% | |
| Efficiency (ROA) | 5.3% ROA vs CWAN's -1.6%, ROIC 15.2% vs 1.1% |
NYAX vs CWAN vs VRNT vs IIIV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NYAX vs CWAN vs VRNT vs IIIV — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NYAX leads in 3 of 6 categories
VRNT leads 1 • CWAN leads 1 • IIIV leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NYAX leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
VRNT is the larger business by revenue, generating $894M annually — 4.1x IIIV's $217M. NYAX is the more profitable business, keeping 8.9% of every revenue dollar as net income compared to CWAN's -5.8%. On growth, CWAN holds the edge at +74.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $404M | $826M | $894M | $217M |
| EBITDAEarnings before interest/tax | $65M | $94M | $127M | $30M |
| Net IncomeAfter-tax profit | $36M | -$48M | $61M | $18M |
| Free Cash FlowCash after capex | $32M | $152M | $118M | $50M |
| Gross MarginGross profit ÷ Revenue | +46.3% | +66.0% | +69.9% | +58.2% |
| Operating MarginEBIT ÷ Revenue | +9.7% | +1.4% | +8.6% | +0.7% |
| Net MarginNet income ÷ Revenue | +8.9% | -5.8% | +6.9% | +8.3% |
| FCF MarginFCF ÷ Revenue | +7.8% | +18.5% | +13.2% | +23.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +37.0% | +74.4% | -1.0% | -8.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +7.0% | -137.9% | -5.1% | — |
Valuation Metrics
VRNT leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 19.7x trailing earnings, VRNT trades at a 72% valuation discount to NYAX's 70.6x P/E. On an enterprise value basis, VRNT's 9.5x EV/EBITDA is more attractive than CWAN's 70.6x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.7B | $7.2B | $1.2B | $467M |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $8.0B | $1.5B | $408M |
| Trailing P/EPrice ÷ TTM EPS | 70.59x | -173.93x | 19.72x | 37.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 81.08x | 34.68x | 7.00x | 18.73x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.02x | — |
| EV / EBITDAEnterprise value multiple | 45.06x | 70.55x | 9.46x | 12.79x |
| Price / SalesMarket cap ÷ Revenue | 6.14x | 9.88x | 1.37x | 2.19x |
| Price / BookPrice ÷ Book value/share | 11.73x | 3.25x | 0.97x | 1.40x |
| Price / FCFMarket cap ÷ FCF | 37.57x | 43.96x | 8.75x | 124.45x |
Profitability & Efficiency
NYAX leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NYAX delivers a 17.5% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-2 for CWAN. IIIV carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to NYAX's 1.46x. On the Piotroski fundamental quality scale (0–9), VRNT scores 7/9 vs CWAN's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.5% | -2.4% | +4.6% | +3.7% |
| ROA (TTM)Return on assets | +5.3% | -1.6% | +2.8% | +2.9% |
| ROICReturn on invested capital | +15.2% | +1.1% | +5.3% | +0.6% |
| ROCEReturn on capital employed | +7.5% | +1.4% | +5.9% | +0.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 7 | 5 |
| Debt / EquityFinancial leverage | 1.46x | 0.43x | 0.34x | 0.01x |
| Net DebtTotal debt minus cash | -$74M | $792M | $233M | -$59M |
| Cash & Equiv.Liquid assets | $412M | $91M | $216M | $67M |
| Total DebtShort + long-term debt | $338M | $883M | $448M | $8M |
| Interest CoverageEBIT ÷ Interest expense | 3.22x | 0.22x | 8.24x | 3.55x |
Total Returns (Dividends Reinvested)
NYAX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NYAX five years ago would be worth $25,769 today (with dividends reinvested), compared to $4,416 for VRNT. Over the past 12 months, NYAX leads with a +74.2% total return vs IIIV's -21.4%. The 3-year compound annual growth rate (CAGR) favors NYAX at 57.2% vs VRNT's -15.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +38.6% | +1.0% | — | -16.3% |
| 1-Year ReturnPast 12 months | +74.2% | +6.1% | +13.8% | -21.4% |
| 3-Year ReturnCumulative with dividends | +288.8% | +66.1% | -39.3% | -10.0% |
| 5-Year ReturnCumulative with dividends | +157.7% | -4.0% | -55.8% | -32.0% |
| 10-Year ReturnCumulative with dividends | +157.7% | -4.0% | -37.1% | +15.2% |
| CAGR (3Y)Annualised 3-year return | +57.2% | +18.4% | -15.3% | -3.5% |
Risk & Volatility
Evenly matched — NYAX and CWAN each lead in 1 of 2 comparable metrics.
Risk & Volatility
NYAX is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than VRNT's 1.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CWAN currently trades 97.1% from its 52-week high vs IIIV's 62.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 0.79x | 1.25x | 0.85x |
| 52-Week HighHighest price in past year | $74.83 | $25.07 | $22.84 | $33.97 |
| 52-Week LowLowest price in past year | $37.95 | $15.74 | $16.23 | $19.89 |
| % of 52W HighCurrent price vs 52-week peak | +96.2% | +97.1% | +89.8% | +62.2% |
| RSI (14)Momentum oscillator 0–100 | 68.2 | 70.8 | 68.4 | 55.5 |
| Avg Volume (50D)Average daily shares traded | 21K | 4.0M | 0 | 301K |
Analyst Outlook
CWAN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NYAX as "Buy", CWAN as "Hold", VRNT as "Hold", IIIV as "Buy". Consensus price targets imply 58.8% upside for VRNT (target: $33) vs -33.3% for NYAX (target: $48). VRNT is the only dividend payer here at 1.56% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $48.00 | $24.96 | $32.57 | $29.00 |
| # AnalystsCovering analysts | 6 | 13 | 16 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.6% | — |
| Dividend StreakConsecutive years of raises | — | 1 | 0 | — |
| Dividend / ShareAnnual DPS | — | — | $0.32 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | +5.8% | +8.1% |
NYAX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). VRNT leads in 1 (Valuation Metrics). 1 tied.
NYAX vs CWAN vs VRNT vs IIIV: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NYAX or CWAN or VRNT or IIIV a better buy right now?
For growth investors, Clearwater Analytics Holdings, Inc.
(CWAN) is the stronger pick with 61. 9% revenue growth year-over-year, versus -7. 3% for i3 Verticals, Inc. (IIIV). Verint Systems Inc. (VRNT) offers the better valuation at 19. 7x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Nayax Ltd. (NYAX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NYAX or CWAN or VRNT or IIIV?
On trailing P/E, Verint Systems Inc.
(VRNT) is the cheapest at 19. 7x versus Nayax Ltd. at 70. 6x. On forward P/E, Verint Systems Inc. is actually cheaper at 7. 0x.
03Which is the better long-term investment — NYAX or CWAN or VRNT or IIIV?
Over the past 5 years, Nayax Ltd.
(NYAX) delivered a total return of +157. 7%, compared to -55. 8% for Verint Systems Inc. (VRNT). Over 10 years, the gap is even starker: NYAX returned +157. 7% versus VRNT's -37. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NYAX or CWAN or VRNT or IIIV?
By beta (market sensitivity over 5 years), Nayax Ltd.
(NYAX) is the lower-risk stock at 0. 72β versus Verint Systems Inc. 's 1. 25β — meaning VRNT is approximately 73% more volatile than NYAX relative to the S&P 500. On balance sheet safety, i3 Verticals, Inc. (IIIV) carries a lower debt/equity ratio of 1% versus 146% for Nayax Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — NYAX or CWAN or VRNT or IIIV?
By revenue growth (latest reported year), Clearwater Analytics Holdings, Inc.
(CWAN) is pulling ahead at 61. 9% versus -7. 3% for i3 Verticals, Inc. (IIIV). On earnings-per-share growth, the picture is similar: Nayax Ltd. grew EPS 737. 5% year-over-year, compared to -108. 3% for Clearwater Analytics Holdings, Inc.. Over a 3-year CAGR, NYAX leads at 35. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NYAX or CWAN or VRNT or IIIV?
Verint Systems Inc.
(VRNT) is the more profitable company, earning 9. 0% net margin versus -5. 3% for Clearwater Analytics Holdings, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRNT leads at 11. 7% versus 1. 9% for IIIV. At the gross margin level — before operating expenses — VRNT leads at 71. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NYAX or CWAN or VRNT or IIIV more undervalued right now?
On forward earnings alone, Verint Systems Inc.
(VRNT) trades at 7. 0x forward P/E versus 81. 1x for Nayax Ltd. — 74. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRNT: 58. 8% to $32. 57.
08Which pays a better dividend — NYAX or CWAN or VRNT or IIIV?
In this comparison, VRNT (1.
6% yield) pays a dividend. NYAX, CWAN, IIIV do not pay a meaningful dividend and should not be held primarily for income.
09Is NYAX or CWAN or VRNT or IIIV better for a retirement portfolio?
For long-horizon retirement investors, Nayax Ltd.
(NYAX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), +157. 7% 10Y return). Both have compounded well over 10 years (NYAX: +157. 7%, IIIV: +15. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NYAX and CWAN and VRNT and IIIV?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NYAX is a small-cap high-growth stock; CWAN is a small-cap high-growth stock; VRNT is a small-cap quality compounder stock; IIIV is a small-cap quality compounder stock. VRNT pays a dividend while NYAX, CWAN, IIIV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.